Response to Anti-hypertensives in Pregnant and Postpartum Patients
Ethnic Differences in Anti-Hypertensive Medication Response Among Pregnant and Postpartum Patients
Sponsor: Icahn School of Medicine at Mount Sinai
This PHASE4 trial investigates Hypertension in Pregnancy and Preeclampsia and is currently completed. Icahn School of Medicine at Mount Sinai leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jun 2021 — Dec 2021 [monthly]
Completed PHASE4
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE4
-
Jul 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Feb 2019 — Jul 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
- Maimonides Medical Center
- Mount Sinai Hospital, New York
For direct contact, visit the study record on ClinicalTrials.gov .